Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2, indicating a minor template/software update; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:31:08.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding notice about operating status. The study details and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T06:52:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page content appears unchanged; observed differences are minor UI/formatting adjustments that do not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:43:25.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a government-status notice and a version upgrade to v3.2.0; removed v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:11:41.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:58:08.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:52:52.000Z thumbnail image

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.